Feasibility and safety of outpatient breast cancer surgery
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Feasibility and safety of outpatient breast cancer surgery. / Duriaud, Helle Molter; Kroman, Niels; Kehlet, Henrik.
In: Danish Medical Journal, Vol. 65, No. 3, 2018.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Feasibility and safety of outpatient breast cancer surgery
AU - Duriaud, Helle Molter
AU - Kroman, Niels
AU - Kehlet, Henrik
N1 - Articles published in the Danish Medical Journal are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
PY - 2018
Y1 - 2018
N2 - INTRODUCTION: Improvement in perioperative care programmes has facilitated post-operative recovery and use of short-term or outpatient procedures. The aim of this study was to assess the feasibility and safety of an outpatient breast cancer programme in patients referred to a large breast cancer unit.METHODS: After an introduction period involving 554 consecutive patients, all patients operated from 1 November 2015 to 30 June 2016 (a total 483 patients) were treated with multimodal oral analgesia, preoperative high-dose glucocorticoids and no routine use of drains. Planned inpatient surgery included patients with mastectomy > 70 years, < 8 h in post-operative observation and < 2 h of observation after mobilisation.RESULTS: Of the 382 patients who were planned for outpatient surgery (79%), 90% received surgery in an outpatient setup. Among the 101 patients (21%) who were planned for inpatient surgery, 17% returned home on the day of surgery. Consequently, the overall outpatient rate was 72% and the overall mean length of stay was 0.3 days, ranging from 0.1 days for breast-conserving surgery to 0.8 days for mastectomy. About 2% were readmitted within < 30 days, mostly due to wound problems. Conclusion: Outpatient breast cancer surgery is feasible and safe in most patients in a socialised healthcare system.FUNDING: none.TRIAL REGISTRATION: not relevant. .
AB - INTRODUCTION: Improvement in perioperative care programmes has facilitated post-operative recovery and use of short-term or outpatient procedures. The aim of this study was to assess the feasibility and safety of an outpatient breast cancer programme in patients referred to a large breast cancer unit.METHODS: After an introduction period involving 554 consecutive patients, all patients operated from 1 November 2015 to 30 June 2016 (a total 483 patients) were treated with multimodal oral analgesia, preoperative high-dose glucocorticoids and no routine use of drains. Planned inpatient surgery included patients with mastectomy > 70 years, < 8 h in post-operative observation and < 2 h of observation after mobilisation.RESULTS: Of the 382 patients who were planned for outpatient surgery (79%), 90% received surgery in an outpatient setup. Among the 101 patients (21%) who were planned for inpatient surgery, 17% returned home on the day of surgery. Consequently, the overall outpatient rate was 72% and the overall mean length of stay was 0.3 days, ranging from 0.1 days for breast-conserving surgery to 0.8 days for mastectomy. About 2% were readmitted within < 30 days, mostly due to wound problems. Conclusion: Outpatient breast cancer surgery is feasible and safe in most patients in a socialised healthcare system.FUNDING: none.TRIAL REGISTRATION: not relevant. .
KW - Aged
KW - Ambulatory Surgical Procedures/adverse effects
KW - Breast Neoplasms/surgery
KW - Denmark
KW - Feasibility Studies
KW - Female
KW - Humans
KW - Length of Stay/statistics & numerical data
KW - Mastectomy/adverse effects
KW - Middle Aged
KW - Outpatients
KW - Pain, Postoperative/etiology
KW - Patient Readmission/statistics & numerical data
KW - Postoperative Period
M3 - Journal article
C2 - 29510807
VL - 65
JO - Danish Medical Journal
JF - Danish Medical Journal
SN - 2245-1919
IS - 3
ER -
ID: 216465655